Showing 5661-5680 of 8875 for: Cochrane Systematic Reviews Back
- Oral contraceptives for functional ovarian cysts
Cochrane Systematic Reviews, 29-Apr-2014
Functional ovarian cysts are a common gynecological problem among women of reproductive age worldwide. When large, persistent, or painful, these cysts may require operations, sometimes resulting in removal of the ovary. Since early oral contraceptives wer
- Oral contraceptives for pain associated with endometriosis
Cochrane Systematic Reviews, 22-May-2018
Endometriosis is a common gynaecological condition which affects many women of reproductive age worldwide and is a major cause of pain and infertility. The combined oral contraceptive pill (COCP) is widely used to treat pain occurring as a result of endom
- Oral corticosteroids for bronchiectasis (stable and acute exacerbations)
Cochrane Systematic Reviews, 23-Apr-2001
Inflammation plays a significant role in the pathophysiology of bronchiectasis. Two small studies have shown small benefits from inhaled corticosteroids and oral corticosteroids may be of benefit in bronchiectasis
- Oral corticosteroids for stable chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 29-Mar-2009
Chronic obstructive pulmonary disease (COPD) is a common chronic lung disorder, usually related to cigarette smoking, representing a major and increasing cause of morbidity and mortality. It is defined "as a disease state characterized by airflow limitati
- Oral deferiprone for iron chelation in people with thalassaemia
Cochrane Systematic Reviews, 21-Aug-2013
Thalassaemia major is a genetic disease characterised by a reduced ability to produce haemoglobin. Management of the resulting anaemia is through red blood cell transfusions.
- Oral dextrose gel for the treatment of hypoglycaemia in newborn infants
Cochrane Systematic Reviews, 18-Mar-2022
Neonatal hypoglycaemia, a common condition, can be associated with brain injury. It is frequently managed by providing infants with an alternative source of glucose, often given enterally with milk-feeding or intravenously with dextrose solution, which ma
- Oral dextrose gel to prevent hypoglycaemia in at‐risk neonates
Cochrane Systematic Reviews, 17-May-2021
Neonatal hypoglycaemia is a common condition that can be associated with brain injury. Current practice usually includes early identification of at-risk infants (e.g. infants of diabetic mothers; preterm, small- or large-for-gestational-age infants), and
- Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis
Cochrane Systematic Reviews, 24-Aug-2015
Deep vein thrombosis (DVT) is a condition in which a clot forms in the deep veins, most commonly of the leg. It occurs in approximately 1 in 1,000 people. If left untreated, the clot can travel up to the lungs and cause a potentially life-threatening pulm
- Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism
Cochrane Systematic Reviews, 4-Dec-2015
Pulmonary embolism is a potentially life-threatening condition in which a clot can travel from the deep veins, most commonly in the leg, up to the lungs. Previously, a pulmonary embolism was treated with the anticoagulants heparin and vitamin K antagonist
- Oral evening primrose oil and borage oil for eczema
Cochrane Systematic Reviews, 30-Apr-2013
Eczema is a chronic inflammatory skin condition, which usually develops in early childhood. Many children outgrow this disorder as they reach secondary school age, and although It may improve with age, there is no cure. Constant itch makes life uncomforta
- Oral fumaric acid esters for psoriasis
Cochrane Systematic Reviews, 10-Aug-2015
Psoriasis is a chronic inflammatory skin condition that can markedly reduce life quality. Several systemic therapies exist for moderate to severe psoriasis, including oral fumaric acid esters (FAE). These contain dimethyl fumarate (DMF), the main active i
- Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants
Cochrane Systematic Reviews, 18-May-2020
Many women express concern about their ability to produce enough milk, and insufficient milk is frequently cited as the reason for supplementation and early termination of breastfeeding. When addressing this concern, it is important first to consider the
- Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema
Cochrane Systematic Reviews, 22-Jan-2019
The symptoms of eczema can lead to sleeplessness and fatigue and may have a substantial impact on quality of life. Use of oral H1 antihistamines (H1 AH) as adjuvant therapy alongside topical agents is based on the idea that combining the anti-inflammatory
- Oral H1 antihistamines as monotherapy for eczema
Cochrane Systematic Reviews, 28-Feb-2013
Eczema is a common skin disease in many countries, and although the majority of cases of eczema occur before the age of five years and often resolve during childhood or adolescence, it can also persist into adulthood. Itch is the most important aspect of
- Oral health education (advice and training) for people with serious mental illness
Cochrane Systematic Reviews, 8-Sep-2016
People with serious mental illness not only experience an erosion of functioning in day-to-day life over a protracted period of time, but evidence also suggests that they have a greater risk of experiencing oral disease and greater oral treatment needs th
- Oral health educational interventions for nursing home staff and residents
Cochrane Systematic Reviews, 30-Sep-2016
Associations between nursing home residents’ oral health status and quality of life, respiratory tract infections, and nutritional status have been reported. Educational interventions for nurses or residents, or both, focusing on knowledge and skills rela
- Oral herbal therapies for treating osteoarthritis
Cochrane Systematic Reviews, 22-May-2014
Medicinal plant products are used orally for treating osteoarthritis. Although their mechanisms of action have not yet been elucidated in full detail, interactions with common inflammatory mediators provide a rationale for using them to treat osteoarthrit
- Oral hygiene care for critically ill patients to prevent ventilator‐associated pneumonia
Cochrane Systematic Reviews, 24-Dec-2020
Ventilator-associated pneumonia (VAP) is defined as pneumonia developing in people who have received mechanical ventilation for at least 48 hours. VAP is a potentially serious complication in these patients who are already critically ill. Oral hygiene car
- Oral hygiene interventions for people with intellectual disabilities
Cochrane Systematic Reviews, 31-May-2019
Periodontal (gum) disease and dental caries (tooth decay) are the most common causes of tooth loss; dental plaque plays a major role in the development of these diseases. Effective oral hygiene involves removing dental plaque, for example, by regular toot
- Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates
Cochrane Systematic Reviews, 4-Apr-2016
Necrotizing enterocolitis (NEC) is the most common emergency involving the gastrointestinal tract occurring in the neonatal period. There have been published reports that suggest that oral immunoglobulins (Ig)A and IgG produce an immunoprotective effect i
